These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 10355394

  • 1. A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations.
    McCarthy PM, Yared JP, Foster RC, Ogella DA, Borsh JA, Cosgrove DM.
    Ann Thorac Surg; 1999 May; 67(5):1268-73. PubMed ID: 10355394
    [Abstract] [Full Text] [Related]

  • 2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
    Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R.
    J Card Surg; 2003 Aug; 18(2):140-6. PubMed ID: 12757341
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study.
    Collart F, Caus T, Pomane C, Pellissier V, Chi Y, Montiès JR, Mesana T.
    Artif Organs; 2000 Aug; 24(8):611-3. PubMed ID: 10971246
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R.
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
    [Abstract] [Full Text] [Related]

  • 7. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E, Am Holen E, Tangen G, Ringdal MA.
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.
    Nilsson J, Scicluna S, Malmkvist G, Pierre L, Algotsson L, Paulsson P, Bjursten H, Johnsson P.
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):834-9. PubMed ID: 22914806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting.
    Jansen PG, Baufreton C, Le Besnerais P, Loisance DY, Wildevuur CR.
    Ann Thorac Surg; 1996 May; 61(5):1363-6. PubMed ID: 8633942
    [Abstract] [Full Text] [Related]

  • 16. 'High dose' aprotinin and heparin-coated circuits: clinical efficacy and inflammatory response.
    Parolari A, Alamanni F, Gherli T, Salis S, Spirito R, Foieni F, Rossi F, Bertera A, Oddono P, Biglioli P.
    Cardiovasc Surg; 1999 Jan; 7(1):117-27. PubMed ID: 10073771
    [Abstract] [Full Text] [Related]

  • 17. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC, Nuttall GA, Ereth MH, Santrach PJ, Buda DA, Schaff HV.
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [Abstract] [Full Text] [Related]

  • 18. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass.
    Lundblad R, Moen O, Fosse E.
    Ann Thorac Surg; 1997 May; 63(5):1361-7. PubMed ID: 9146328
    [Abstract] [Full Text] [Related]

  • 19. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E, Thelin S, Svennevig JL, Jansen P, Mollnes TE, Hack E, Venge P, Moen O, Brockmeier V, Dregelid E, Haldén E, Hagman L, Videm V, Pedersen T, Mohr B.
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [Abstract] [Full Text] [Related]

  • 20. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B, Sutlic Z.
    Heart Surg Forum; 2002 Feb; 5(2):182-6. PubMed ID: 12125670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.